# US 2016/0235068 A1 · Controlled release particles, production method thereof, molding material, and molded article

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0235068 A1
- Document ID: US20160235068A1
- Status: Published application
- Kind: A1
- Application number: 14/914,949
- Filed: 2014-08-29
- Published: 2016-08-18
- Earliest claimed: 2013-08-30
- Assignees: Osaka Gas Chemicals Co., Ltd.
- Applicants: Osaka Gas Chemicals Co., Ltd.
- Inventors: Junji OSHIMA; Hideaki INOUE; Tomoko HOSHINO; Ayako KOBAYASHI
- Web page: https://patentgrep.com/patent/US20160235068A1

## CPC

- A01N 25/26: in coated particulate form
- A01N 25/28: Microcapsules {or nanocapsules}
- A61K 9/5026: {obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates}
- A61K 9/5089: {Processes}
- B01J 13/16: Interfacial polymerisation
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS

## Abstract

A production method of controlled release particles 1 includes an oil phase component preparation step in which an oil phase component containing a hydrophobic slurry is prepared by dispersing, in a hydrophobic polymerizable vinyl monomer, an antibiotic compound that is hydrophobic and is substantially insoluble to the hydrophobic polymerizable vinyl monomer without the presence of a solvent; a water dispersion step in which a hydrophobic slurry is dispersed in water to prepare an aqueous dispersion; and a polymerization step in which the polymerizable vinyl monomer is subjected to suspension polymerization to produce a polymer.

## Claims

### Claim 1

The controlled release particles produced by a production method including:
an oil phase component preparation step in which an oil phase component containing a hydrophobic slurry is prepared by dispersing, in the hydrophobic polymerizable vinyl monomer, an antibiotic compound that is hydrophobic and is substantially insoluble to the hydrophobic polymerizable vinyl monomer without the presence of a solvent,
a water dispersion step in which the oil phase component is dispersed in water to prepare an aqueous dispersion, and
a polymerization step in which the polymerizable vinyl monomer is subjected to suspension polymerization to produce a polymer.

### Claim 2 (depends on 1)

The controlled release particles according to claim 1,
wherein in the polymerization step, the polymerizable vinyl monomer is subjected to suspension polymerization in the presence of a salt of a condensate of aromatic sulfonic acid and formaldehyde, and/or
the polymerizable vinyl monomer contains a (meth)acrylate monomer and a (meth)acrylate-based crosslinkable monomer.

### Claim 3 (depends on 1)

The controlled release particles according to claim 1, wherein the antibiotic compound is a neonicotinoid-based insecticide.

### Claim 4 (depends on 3)

The controlled release particles according to claim 3, wherein the neonicotinoid-based insecticide contains at least one selected from the group consisting of (E)-1-(2-chlorothiazole-5-ylmethyl)-3-methyl-2-nitroguanidine and 1-(6-chloro-3-pyridylmethyl)-N-nitroimidazolidin-2-ylideneamine.

### Claim 5

Controlled release particles having a two-phase structure formed from
a matrix made of a polymer, and
a domain made of an antibiotic compound substantially insoluble to a monomer for producing the polymer and is dispersed in the matrix.

### Claim 6 (depends on 5)

The controlled release particles according to claim 5, wherein both of the matrix and the domain are exposed on the surface of the controlled release particles.

### Claim 7 (depends on 5)

The controlled release particles according to claim 5, wherein the domain is covered by the matrix.

### Claim 8 (depends on 7)

The controlled release particles according to claim 7, wherein the antibiotic compound is further attached to the surface of the matrix.

### Claim 9 (depends on 5)

The controlled release particles according to claim 5, wherein the antibiotic compound is a neonicotinoid-based insecticide.

### Claim 10 (depends on 9)

The controlled release particles according to claim 9, wherein the neonicotinoid-based insecticide contains at least one selected from the group consisting of (E)-1-(2-chlorothiazole-5-ylmethyl)-3-methyl-2-nitroguanidine and 1-(6-chloro-3-pyridylmethyl)-N-nitroimidazolidin-2-ylideneamine.

### Claim 11 (depends on 1)

The controlled release particles according to claim 1, prepared as powder formulation.

### Claim 12

A molding material comprising:
a thermoplastic resin, and
controlled release particles,
wherein
the controlled release particles are produced by a production method including:
an oil phase component preparation step in which an oil phase component containing a hydrophobic slurry is prepared by dispersing, in a hydrophobic polymerizable vinyl monomer, an antibiotic compound that is hydrophobic and is substantially insoluble to the hydrophobic polymerizable vinyl monomer without the presence of a solvent,
a water dispersion step in which the oil phase component is dispersed in water to prepare an aqueous dispersion, and
a polymerization step in which the polymerizable vinyl monomer is subjected to suspension polymerization to produce a polymer.

### Claim 13

A molded article comprising:
a thermoplastic resin, and
controlled release particles,
wherein
the controlled release particles are produced by a production method including:
an oil phase component preparation step in which an oil phase component containing a hydrophobic slurry is prepared by dispersing, in a hydrophobic polymerizable vinyl monomer, an antibiotic compound that is hydrophobic and is substantially insoluble to the hydrophobic polymerizable vinyl monomer without the presence of a solvent,
a water dispersion step in which the oil phase component is dispersed in water to prepare an aqueous dispersion, and
a polymerization step in which the polymerizable vinyl monomer is subjected to suspension polymerization to produce a polymer.

### Claim 14

A method for producing controlled release particles, the method comprising the steps of:
an oil phase component preparation step in which an oil phase component containing a hydrophobic slurry is prepared by dispersing, in a hydrophobic polymerizable vinyl monomer, an antibiotic compound that is hydrophobic and is substantially insoluble to the hydrophobic polymerizable vinyl monomer without the presence of a solvent,
a water dispersion step in which the oil phase component is dispersed in water to prepare an aqueous dispersion, and
a polymerization step in which the polymerizable vinyl monomer is subjected to suspension polymerization to produce a polymer.

### Claim 15 (depends on 14)

The method for producing controlled release particles according to claim 14, wherein
in the polymerization step, the polymerizable vinyl monomer is subjected to suspension polymerization in the presence of a salt of a condensate of aromatic sulfonic acid and formaldehyde, and/or
the polymerizable vinyl monomer contains a (meth)acrylate monomer and a (meth)acrylate-based crosslinkable monomer.

### Claim 16 (depends on 14)

The method for producing controlled release particles according to claim 14, further including a step of preparing powder formulation by blending the suspension produced in the polymerization step and a solid carrier, and drying these.

### Claim 17 (depends on 14)

The method for producing controlled release particles according to claim 14, wherein the antibiotic compound is a neonicotinoid-based insecticide.

### Claim 18 (depends on 17)

The method for producing controlled release particles according to claim 17, wherein the neonicotinoid-based insecticide contains at least one selected from the group consisting of (E)-1-(2-chlorothiazole-5-ylmethyl)-3-methyl-2-nitroguanidine and 1-(6-chloro-3-pyridylmethyl)-N-nitroimidazolidin-2-ylideneamine.

### Claim 19

Controlled release particles produced by a production method including:
an oil phase component preparation step in which an oil phase component containing a hydrophobic slurry is prepared by dispersing, in a hydrophobic polymerizable vinyl monomer, an antibiotic compound that is hydrophobic and is substantially insoluble to the hydrophobic polymerizable vinyl monomer without the presence of a solvent,
a water dispersion step in which the oil phase component is dispersed in water to prepare an aqueous dispersion, and
a polymerization step in which the polymerizable vinyl monomer is subjected to suspension polymerization to produce a polymer,
wherein
in any of at least one step of the oil phase component preparation step, the water dispersion step, and the polymerization step, a hydrophobic shell-forming component and a hydrophilic-shell forming component are blended, and
in the polymerization step, the polymerizable vinyl monomer is subjected to suspension polymerization and the hydrophobic shell-forming component and the hydrophilic shell-forming component are subjected to interfacial polymerization to form a shell that covers a suspension polymer.

### Claim 20 (depends on 19)

The controlled release particles according to claim 19, wherein the interfacial polymerization is started simultaneously with the start of the suspension polymerization, or is started before the start of the suspension polymerization.

### Claim 21 (depends on 19)

The controlled release particles according to claim 19, wherein the hydrophobic shell-forming component contains polyisocyanate, and
the hydrophilic shell-forming component contains polyamine.

### Claim 22 (depends on 19)

The controlled release particles according to claim 19, wherein the antibiotic compound is a neonicotinoid-based insecticide.

### Claim 23 (depends on 22)

The controlled release particles according to claim 22, wherein the neonicotinoid-based insecticide contains at least one selected from the group consisting of (E)-1-(2-chlorothiazole-5-ylmethyl)-3-methyl-2-nitroguanidine and 1-(6-chloro-3-pyridylmethyl)-N-nitroimidazolidin-2-ylideneamine.

### Claim 24

Controlled release particles comprising:
a matrix made of a polymer,
a domain made of an antibiotic compound substantially insoluble to a monomer for producing the polymer and is dispersed in the matrix, and
a shell that covers the matrix.

### Claim 25 (depends on 24)

The controlled release particles according to claim 24, wherein the shell is made of polyurea.

### Claim 26 (depends on 24)

The controlled release particles according to claim 24, wherein the antibiotic compound is attached to the surface of the shell.

### Claim 27 (depends on 24)

The controlled release particles according to claim 24, wherein the antibiotic compound is a neonicotinoid-based insecticide.

### Claim 28 (depends on 27)

The controlled release particles according to claim 27, wherein the neonicotinoid-based insecticide contains at least one selected from the group consisting of (E)-1-(2-chlorothiazole-5-ylmethyl)-3-methyl-2-nitroguanidine and 1-(6-chloro-3-pyridylmethyl)-N-nitroimidazolidin-2-ylideneamine.

### Claim 29 (depends on 19)

The controlled release particles according to claim 19, prepared as powder formulation.

### Claim 30

A molding material comprising:
a thermoplastic resin, and
controlled release particles,
wherein
the controlled release particles are produced by a production method including:
an oil phase component preparation step in which an oil phase component containing a hydrophobic slurry is prepared by dispersing, in a hydrophobic polymerizable vinyl monomer, an antibiotic compound that is hydrophobic and is substantially insoluble to the hydrophobic polymerizable vinyl monomer without the presence of a solvent,
a water dispersion step in which the oil phase component is dispersed in water to prepare an aqueous dispersion, and
a polymerization step in which the polymerizable vinyl monomer is subjected to suspension polymerization to produce a polymer, and
in any of at least one step of the oil phase component preparation step, the water dispersion step, and the polymerization step, a hydrophobic shell-forming component and a hydrophilic-shell forming component are blended, and
in the polymerization step, the polymerizable vinyl monomer is subjected to suspension polymerization and the hydrophobic shell-forming component and the hydrophilic shell-forming component are subjected to interfacial polymerization to form a shell that covers a suspension polymer.

### Claim 31

A molded article comprising:
a thermoplastic resin, and
controlled release particles
wherein
the controlled release particles are produced by a production method including:
an oil phase component preparation step in which an oil phase component containing a hydrophobic slurry is prepared by dispersing, in a hydrophobic polymerizable vinyl monomer, an antibiotic compound that is hydrophobic and is substantially insoluble to the hydrophobic polymerizable vinyl monomer without the presence of a solvent,
a water dispersion step in which the oil phase component is dispersed in water to prepare an aqueous dispersion, and
a polymerization step in which the polymerizable vinyl monomer is subjected to suspension polymerization to produce a polymer, and
in any of at least one step of the oil phase component preparation step, the water dispersion step, and the polymerization step, a hydrophobic shell-forming component and a hydrophilic-shell forming component are blended, and
in the polymerization step, the polymerizable vinyl monomer is subjected to suspension polymerization and the hydrophobic shell-forming component and the hydrophilic shell-forming component are subjected to interfacial polymerization to form a shell that covers a suspension polymer.

### Claim 32

A method for producing controlled release particles, the method comprising the steps of:
an oil phase component preparation step in which an oil phase component containing a hydrophobic slurry is prepared by dispersing, in a hydrophobic polymerizable vinyl monomer, an antibiotic compound that is hydrophobic and is substantially insoluble to the hydrophobic polymerizable vinyl monomer without the presence of a solvent,
a water dispersion step in which the oil phase component is dispersed in water to prepare an aqueous dispersion, and
a polymerization step in which the polymerizable vinyl monomer is subjected to suspension polymerization to produce a polymer,
wherein
in any of at least one step of the oil phase component preparation step, the water dispersion step, and the polymerization step, a hydrophobic shell-forming component and a hydrophilic-shell forming component are blended, and
in the polymerization step, the polymerizable vinyl monomer is subjected to suspension polymerization and the hydrophobic shell-forming component and the hydrophilic shell-forming component are subjected to interfacial polymerization to form a shell that covers a suspension polymer.

### Claim 33 (depends on 32)

The method for producing controlled release particles according to claim 32, wherein in the polymerization step, interfacial polymerization is started simultaneously with the start of the suspension polymerization, or is started before the start of the suspension polymerization.

### Claim 34 (depends on 32)

The method for producing controlled release particles according to claim 32, wherein
the hydrophobic shell-forming component is polyisocyanate, and
the hydrophilic shell-forming component is polyamine.

### Claim 35 (depends on 32)

The method for producing controlled release particles according to claim 32, further including a step of preparing powder formulation by blending the suspension produced in the polymerization step and a solid carrier, and drying these.

### Claim 36 (depends on 32)

The method for producing controlled release particles according to claim 32, wherein the antibiotic compound is a neonicotinoid-based insecticide.

### Claim 37 (depends on 36)

The method for producing controlled release particles according to claim 36, wherein the neonicotinoid-based insecticide contains at least one selected from the group consisting of (E)-1-(2-chlorothiazole-5-ylmethyl)-3-methyl-2-nitroguanidine and 1-(6-chloro-3-pyridylmethyl)-N-nitroimidazolidin-2-ylideneamine.
